ArticleTobacco induced diseases2025
Association between serum cotinine and learning disability in children aged 4-15 years: A secondary data analysis from the NHANES dataset.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWhile prior studies suggest links between secondhand smoke (SHS) exposure and developmental impairment, evidence linking objective biomarkers of SHS exposure to learning disability (LD) in children remains limited. This study investigates the association between serum cotinine - a validated biomarker of SHS exposure - and the higher likelihood of LD in US children.
methodsThis secondary analysis utilized cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002, including 2573 children aged 4-15 years. Multivariable logistic regression models were implemented to evaluate the association between serum cotinine and parent-reported LD diagnoses. The dose-dependent relationship between cotinine and LD was analyzed using smooth curve fitting. Subgroup analyses were evaluated to assess robustness.
resultsMultivariable logistic regression analysis revealed that each unit increase in log-transformed cotinine was associated with a 1.81-fold increase in the odds of LD (AOR=1.81; 95% CI: 1.21-2.70, p<0.01). Children in the highest cotinine quartile exhibited 2.38-fold higher odds of LD compared to those in the lowest quartile (AOR=2.38; 95% CI: 1.23-4.58, p=0.01). Dose-response analysis revealed a linear relationship between log cotinine and LD (p for nonlinearity=0.20). Subgroup analyses further confirmed the stability of these results (p for interaction >0.05).
conclusionsThe findings indicate a significant association between serum cotinine and an increased likelihood of LD in US children. The dose-dependent and linear nature of this relationship advocate for stricter smoke-free policies and targeted educational campaigns to reduce potential neurodevelopmental harms in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.